Objective: to examine the expression of transforming growth factor b1 (TGF-b1) and the cell kinetics of smooth muscle cells (SMCs) at the neck of abdominal aortic aneurysms (AAAs). Materials and Methods: expression of a-smooth muscle actin and TGF-b1 was evaluated by immunostaining, and cell kinetics were estimated by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) assay and Ki-67 immunostaining in 11 AAAs (at both the dilated region and the neck) and eight occlusive aortas. Results: the TUNEL-positive SMC ratio in the neck and dilated region was significantly higher than in the occlusive aorta (p 5 0.01). The percentage of Ki-67-positive SMCs in the neck was significantly higher than in the dilated region (p 5 0.01) and the occlusive aorta (p 0.032). When compared with the occlusive aorta, the aneurysmal neck had increased TGF-b1 expression (p 0.01) and reduced SMC density, and the aneurysmal dilated aorta had much more increased TGF-b1 expression (p 5 0.01) and much more reduced SMC density (p 5 0.01). Conclusions: these results suggest that overexpression of TGF-b1 might be associated with the reduction of SMC density through SMC apoptosis and reduced proliferative ability of SMCs, leading to dilatation in AAAs.
Introduction
Infrarenal abdominal aortic aneurysms (AAAs) are characterised by intimal atherosclerosis, which is similar to arteriosclerosis obliterans (ASO), and degeneration of the medial layer associated with a pronounced decrease in aortic elastin fibers, 1,2 which is different from ASO. Vascular smooth muscle cells (SMCs) are the physiologically dominant cells in the medial layer. According to some recent reports, apoptosis of SMCs has been observed in the degenerate media AAAs. 3±5 However, as SMCs are capable of regeneration and proliferation in injured vessels, 6 SMCs may be regenerated to proliferate with AAA aneurysm. Transforming growth factor b1 (TGF-b1) is a pleiotropic factor expressed within vascular cells, and regulates cell growth in a tissue-specific manner. TGF-b1 has been reported to arrest growth in the G1 phase of the cell cycle, 7 and to play an important role as an inducer of apoptosis in a variety of cells. 8±10 Although it has been reported that TGF-b1 inhibits the proliferation of vascular SMCs, 11 no study has yet demonstrated the expression of TGF-b1 in SMCs of AAAs.
In this study, we examined the expression of TGF-b1 and the cell kinetics of SMCs both at the region of aneurysmal neck and aneurysmal dilation to assess the relationship between TGF-b1 expression and aneurysm formation.
Materials and Methods

Tissue preparation
Approval from the Medical Ethics Committee of Shinshu University School of Medicine was obtained for collection of samples. Informed consent was obtained from the patients. Because the medial layer of the occlusive aorta has histologically normal SMCs 3 and both aneurysmal aorta and occlusive aorta have similar intimal changes, we compared the medial layer of AAA with that of occlusive aortas. An anterolateral section of aorta (ASO cases), the AAA neck and dilated region, were collected during surgery from eight occlusive and 11 aneurysmal human aortas. In this study, aneurysmal neck refers to the border area where aneurysmal enlargement begins. Ruptured, thoracoabdominal and inflammatory aneurysms were excluded from the study. The average diameter of the AAAs was 5.1 (range, 4.1±6.0 cm). The average age was 74 (range, 55±83) years for patients with AAAs, and 67.5 (range, 50±81) years for patients with ASO (Table 1) . Specimens were fixed immediately in 8% paraformaldehyde at 4 C for 20±22 h, and then embedded in paraffin.
a-Smooth muscle actin and TGF-b1 immunostaining
Specimens were cut into 4-mm serial sections onto glass slides coated with poly-l-lysine. Four serial sections were prepared, and a-actin immunostaining was performed using the second or third section. Deparaffinized rehydrated tissues were incubated in methanol containing 0.3% hydrogen peroxidase for 30 min to block the endogenous peroxidase activity. The sections were washed in 0.01 mol/L Tris-HCl (pH 7.5)/ 150 mmol/L NaCl (TBS), and blocked with 1% bovine serum albumin (BSA) (Sigma, St Louis, MO, U.S.A.). For a-smooth muscle immunostaining, the sections were incubated at room temperature for 1 h with alkaline phosphatase-conjugated anti-a-smooth muscle actin (Sigma) in 1% BSA, and the reaction product was developed using New Fuchsin substrate (DAKO). For TGF-b1 immunostaining, the sections were incubated at room temperature for 1 h with anti-TGF-b1 antibody (Santa Cruz, CA, U.S.A.) at a dilution of 1:500 in 1% BSA, and antibody binding was visualized using the streptavidin-biotin system (DAKO, Glostrup, Denmark) and 3,3-diaminobenzidine. Staining development was stopped by immersion in tap water, and nuclei were counterstained with hematoxylin. In negative controls, all reagents except the primary antibody were used.
Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) assay
To detect cells undergoing apoptosis, the tissue sections were stained using the TUNEL procedure with some modifications. The tissue sectioned at 4 mm was dewaxed, rehydrated, and digested with 20 mg/mL proteinase K (Sigma). Endogenous peroxidase was blocked by treatment with 0.3% hydrogen peroxidase. Sections were then rinsed in water and incubated with 50 mL of terminal deoxynucleotidyl transferase (TdT) buffer (30 mmol/L Tris-HCl [pH 7.2], 140 mmol/L sodium cacodylate, 1 mmol/L cobalt chloride) containing 8.3 U TdT (Boehringer Mannheim, Mannheim, Germany) and 0.83 nmol biotinylated 16-deoxyuridine triphosphate (Boehringer±Mannheim) in a moist chamber at 37 C for 60 min. Then, the sections were rinsed and incubated with HRP-conjugated streptavidin (DAKO) diluted 1:500 in TBS containing 1% BSA for 30 min at room temperature, then rinsed in TBS and stained with diaminobenzidine.
Ki-67 immunostaining
Proliferative activity of aortic SMCs was detected by immunostaining for Ki-67 protein in the nuclei of cells. After the 4-mm sections had been dewaxed, antigen retrieval was performed using a microwave oven. Endogenous peroxidase blocking was then performed. Sections were incubated with 100 mg/mL anti-human mouse monoclonal Ki-67 antibody (DAKO) at a dilution of 1:50 for 90 min at 37 C. Antibody binding was visualized using the labeled streptavidin biotin (LSAB) method (DAKO LSAB Kit), and 3,3-diaminobenzidine. Then, cell nuclei were counterstained with hematoxylin and mounted.
Morphological analysis
Color images of the immunohistochemically stained sections at 400 magnification were saved in a Macintosh personal computer (Apple Computers, Cupertino, CA, U.S.A.) using a Fujix digital camera HC 2500 (Fuji Photo Film Co., Ltd, Tokyo, Japan) and computer-assisted image analysis software, NIH Image version 1.60 (National Institutes of Health, Bethesda, MD, U.S.A.). The captured images were projected on the computer monitor. The immunohistochemical staining was analyzed by two independent observers in a blind manner.
First, a randomly chosen color image on the aactin-immunostained section was viewed on the monitor, and the number of a-actin-positive cells were counted and recorded. The same field in the TGF-b1-immunostained (or TUNEL assay or Ki-67 immunostained) section was then identified and displayed next to the a-actin immunostaining image on the monitor. Then, TGF-b1-positive cells (or apoptotic cells or Ki-67-positive cells) were identified by one-to-one correspondence with a-actin-positive cells on the monitor, and the positive cells were counted. These procedures were repeated in four randomly chosen areas.
Statistical analysis
The differences were evaluated with the Mann± Whitney U test for comparison between occlusive aortas and aneurysmal necks or between occlusive aortas and aneurysmal dilated regions, and with the Wilcoxon signed rank sum test for comparison between aneurysmal necks and aneurysmal dilated regions. All analyses were performed with the Statview 5.0 statistical software package (Abacus Concepts, Berkley, CA, U.S.A.). The results are presented as median (range) and are considered significant at p 5 0.05.
Results
The a-actin antibody-positive SMCs predominated in the medial layer of the occlusive aorta and the aneurysmal neck, but SMCs in the aneurysmal dilated region showed a disrupted and disorganized pattern (Fig. 1A ). The aneurysmal dilated had significantly fewer SMCs in the medial layer compared with the occlusive aorta (p 5 0.01) and the aneurysmal neck (p 5 0.01) ( Table 1 ). There was a significant difference in SMC density between the aneurysmal neck and the occlusive aorta (p 5 0.01).
The ratio of TUNEL-positive SMCs in the aneurysmal neck (29%, range 8±34%) was significantly increased compared with that in the occlusive aorta (12%, range 4±17%, p 5 0.01). The ratio of TUNELpositive SMCs in the aneurysmal dilated region (40%, range 4±59%) varied widely among patients but significantly increased compared with that in the occlusive aorta (p 5 0.01) and aneurysmal neck (p 0.015) (Figs 1B and 2) .
Proliferating SMCs were observed in the medial layer of AAAs with Ki-67 immunostaining. The percentage of Ki-67-positive SMCs in the aneurysmal neck (3.6%, range 0±6.8) was significantly higher than in the aneurysmal dilated region (0.5%, range 0±6.1, p 5 0.01) and the occlusive aorta (1.2%, range 0±2.9, p 0.032) (Table 1, Fig. 1C) .
TGF-b1-positive SMCs were visualized in the aortic media. The ratio of TGF-b1-positive SMCs in the aneurysmal dilated region (42%, range 29±60%) was much higher than that in the aneurysmal neck (13%, range 10±27%, p 5 0.01) and that in the occlusive aorta (7%, range 5±17% p 5 0.01) (Fig. 1D) . The ratio of TGF-b1-positive SMCs in the aneurysmal neck was significantly higher than that in the occlusive aorta (p 0.01) (Fig. 3) . Figure 4 shows the relationship between TGF-b1 expression and SMC density in the occlusive aorta, the aneurysmal neck, and the aneurysmal dilated region. Compared with the occlusive aorta, the neck had increased TGF-b1 expression and reduced SMC density, and the aneurysmal dilated aorta had much more increased TGF-b1 expression and much more reduced SMC density.
Discussion
Many studies has shown AAA, to be associated with diminished elastin content, 1,12,13 predominance of destructive proteases such as MMP-2 and MMP-9, 14±16 and apoptosis of SMCs. 3±5 However, a histological approach using the aneurysmal dilated region alone, which is severely damaged and the final state of the condition, can provide little information about the etiology of AAAs. Therefore, in this study, we investigated the aneurysmal neck as the border area for aneurysmal enlargement.
Lopez-Candales et al. documented a decrease of SMC density and an increased number of apoptotic SMCs in the media AAAs. 3 Thompson et al. also found an increased number of apoptotic SMCs in aneurysmal aortic tissue when compared with normal human aorta. 4 However, these studies did not refer to the regional differences of SMC density or SMC apoptosis in AAAs. It is postulated that vascular lesion formation and remodeling involves a balance between vascular cell death and cell proliferation. There has been no report on imbalance between SMC apoptosis and proliferation in AAAs. Studies of possible imbalance are important for research on the etiology of AAAs, as shown by Isner et al., who reported that apoptosis may, by proliferation of SMCs, modulate the cellularity of lesions that produce human coronary vascular obstruction. 17 Therefore, we compared aneurysmal necks with occlusive aortas in terms of the balance between SMC death and proliferation. We found that the increased SMC apoptosis was accompanied by a decrease in SMC density in the aneurysmal neck, and Ki-67 immunostaining showed accentuation of SMC proliferation only in the aneurysmal neck of the AAAs. These findings indicate that, while SMC proliferation occurs at the aneurysmal neck, it does not compensate for SMC apoptosis, and thus SMC density is reduced in the aneurysmal neck. This suggests that aneurysmal dilatation could begin in the aneurysmal neck.
Recently, many reports have referred to the modulation by TGF-b1 in vascular smooth muscle cell apoptosis.
8,11,18±20 However, no reports have documented the expression of TGF-b1 in SMCs of AAAs. In the present study we focused the expression of TGF-b1, which is reported to have important role to inhibit the proliferation of vascular SMCs, 11 both in the aneurysmal neck and in the aneurysmal dilated region to assess the relationship between TGF-b1 expression and aneurysm formation. And it was revealed that the aneurysmal neck had increased TGF-b1 expression and reduced SMC density, and the aneurysmal dilated region had much more increased TGF-b1 expression and much more reduced SMC density, when compared with the occlusive aorta. Together with the generally accepted apoptotic function of TGF-b1, it is suggested that overexpression of TGF-b1 might be associated with the reduction of SMC density through SMC apoptosis and reduced proliferative ability of SMCs, leading to aneurysmal dilatation in AAAs. Moreover we suppose that increased TGF-b1 expression in SMCs might associated with the trigger of aneurysmal dilatation in the early period of vascular remodelling because TGF-b1 expression in SMCs has already increased in the aneurysmal neck.
